"We are committed to become the global leader
in MEDLab business and contribute
to healthy lives of the people."
In 1972, GCMS started with the introduction of the first blood grouping. For the past 40 years, we have been accumulating high technology and know-how in the field of medical devices and diagnostic reagents. We have proved ourselves as a matchless Total Medical Device Company through aggressive business diversification such as blood glucose business, kidney hemodialysis business, and blood bag business with application of our know-how in in-vitro diagnostics.
To pursuit healthy life through diagnosis and prevention is the main value of GCMS.
To that end, GCMS strive to secure the next generation IVD technology that enables diagnosis and the most optimal treatment at each stage of diseases. Furthermore, we are strengthening our molecular diagnostics and NGS(Next Generation Sequencing) based analysis technology for gene diagnosis products. In addition, through convergence with IT environment such as mobile healthcare, we will leap toward becoming the leading company in medical device market.
Becoming the indispensable company for happy and healthy life
To build such priceless value, GCMS will advance toward the bigger world with you.